Cerebral Infarction: A Risk after Bacterial Meningitis

Published Online: Sunday, January 29, 2012
Follow Pharmacy_Times:
A recent study conducted at the University of Amsterdam has found that cerebral infarction is a serious concern in adults who contract community-acquired bacterial meningitis. They indicate that steps taken to prevent cerebral infarction would decrease morbidity and mortality.

Approximately 80% to 85% of all bacterial meningitis is caused by Streptococcus pneumoniae or Neisseria meningitides; morbidity is 30% and 10%, respectively. Cerebrovascular complications are especially common in patients who have pneumoccal meningitis, with up to 29% affected.

These researchers looked at 696 patients, 25% of whom experienced a cerebral infarction pursuant to meningitis.  They identified several factors that increase the likelihood of cerebral infarction: older age, low level of consciousness, systemic inflammation, and infection with S. pneumonia.

More work is needed to determine if drug therapies can be used adjunctively to prevent cerebral infarction. 

Related Articles
A reduction in pediatric health care visits related to otitis media between 2001 and 2011 appears to be due to uptake of the pneumococcal conjugate vaccine, according to the results of a new study.
A new study finds that decreased rates of infection with serotypes of pneumococcal disease the PCV7 vaccine protects against outweigh increased rates of infection with serotypes it does not protect against.
Streptococcus pneumoniae is the leading cause of life-threatening illness globally.
A decade after the 7-valent pneumococcal conjugate vaccine was introduced, it led to approximately 168,000 fewer annual hospitalizations for pneumonia.
Latest Issues
$auto_registration$